Renalytix Plc (AIM:RENX)
London
· Delayed Price · Currency is GBP · Price in GBX 8.00
0.00 (0.00%)
Apr 17, 2025, 4:42 PM GMT+1
Renalytix Market Cap
Renalytix has a market cap or net worth of 26.50 million as of April 21, 2025. Its market cap has decreased by -25.46% in one year.
Market Cap
26.50M
Enterprise Value
25.36M
Revenue
2.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.00
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 26.50M, a decrease of -58.97%. That is a compound annual growth rate of -12.90%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 156.99B |
| GSK plc | 54.15B |
| Haleon | 34.34B |
| Smith & Nephew | 8.61B |
| ConvaTec Group | 5.18B |
| Hikma Pharmaceuticals | 4.16B |
| HUTCHMED (China) | 1.81B |
| Oxford Nanopore Technologies | 1.13B |